Jump to content

Results of the First Phase of Human Trials of Thai COVID-19 Vaccine Are Promising


webfact

Recommended Posts

7317ab8b53b94056597a5d3ccc7d0fa6_small.jpg

 

By Subhabhong Rarueysong

   

BANGKOK (NNT) - Thailand’s Government Pharmaceutical Organization (GPO) has reported that the results of the first phase of human trials of a COVID-19 vaccine candidate, being developed by the GPO and Mahidol University’s faculty of tropical medicine, are promising and the official results will be released next month.

 

GPO Director Dr. Vitoon Danwiboon said the first phase trial of HXP-GPOVac, which uses inactivated virus technology, has produced positive results in terms of safety and triggering an immune response. Samples have been sent for analyses in labs, run by the Department of Medical Sciences and National Science and Technology Development Agency, as well as to labs overseas.

 

He said two out of five formulae will be selected for the next phase, with a group of 250 volunteers, and the one showing most promise will be used in the trial’s third phase.

 

According to Dr. Vitoon, HXP-GPOVac was developed using a different technology, aimed at triggering immunity against virus mutations. It is also effective against the Alpha variant and tests are underway to determine its effectiveness against the Beta and Delta variants.

 

nnt.jpg
  • Like 2
Link to comment
Share on other sites

2 hours ago, RichardColeman said:

Considering the Delta s about to decimate Thailand's health system , if its not effective they may as well abandon what they have and start again

 

The delta variant is about to decimate Thailand's health system?? Really?  Any sources for this rather outlandish claim?

  • Like 2
  • Confused 1
Link to comment
Share on other sites

2 hours ago, DrJack54 said:

Why reinvent the wheel.

Import the bloody vaccine. Beg borrow or steal.

 

Why not just buy more AZ from SB?

And if all its undistributed inventory is llegedly destined for sale (16 million doses) to the Philippines, deny export as a matter of national security and distribute to Thai residents first.

Link to comment
Share on other sites

5 hours ago, RichardColeman said:

Considering the Delta s about to decimate Thailand's health system , if its not effective they may as well abandon what they have and start again

On top of that Al Jazeera has reported that there is now a Delta+ variant.  

Link to comment
Share on other sites

Now the monkey is out of the sleeve , they where waiting for this all along so they could use their own imstead of spending billions of baht ordering( now this money can be pocketed as a large portion already has been and they where a bit short but that certenly will not show now)

  • Like 1
Link to comment
Share on other sites

I wrote about this months ago already , the NDV-HXP-S vaccine looked very promising and being produced in Thailand , Vietnam . It is being cultivated inside chicken eggs and very cheap to make and can be made by millions . Took a while for them to finaly tell the masses about it . 

Link to comment
Share on other sites

6 hours ago, RichardColeman said:

Considering the Delta s about to decimate Thailand's health system , if its not effective they may as well abandon what they have and start again

This old technology seems inappropriate for a fast mutating virus. The Chinese vaccines offer insight into this issue.

  • Haha 1
Link to comment
Share on other sites

1 hour ago, Srikcir said:

Why not just buy more AZ from SB?

And if all its undistributed inventory is llegedly destined for sale (16 million doses) to the Philippines, deny export as a matter of national security and distribute to Thai residents first.

Maybe you will never travel again, Bud, but everybody needs jabs no matter where they live. I believe this was Siam BS' contractual obligations to other countries.

Link to comment
Share on other sites

2 hours ago, rwill said:

I thought I remembered an earlier article saying it was mRNA based.  But now inactivated virus based, which does make more sense.  

 

Chulalongkorn is developing the mRNA vaccine that just started Phase I trials. Prof Drew Weissman at University of Pennsylvania, noted pioneer of mRNA technology, has been working with them.

 

https://www.chula.ac.th/en/clipping/47302/

 

  • Like 1
Link to comment
Share on other sites

If this is in fact a mRNA vaccine, which only two companies know how to produce (that took more than a decade of research), and it can be stored at cool and room temperature, this should be a world news headline!

Link to comment
Share on other sites

2 hours ago, rwill said:

I thought I remembered an earlier article saying it was mRNA based.  But now inactivated virus based, which does make more sense.  

There were a number of different Thai vaccines being developed. The one from Chulalongkorn University is mRNA-based, this one (from Mahidol University) isn't.

  • Like 1
Link to comment
Share on other sites

8 hours ago, Thaiwrath said:

You could release the results now.

Prediction: There were no side effects or adverse conditions shown by any of the volunteers, and Thailand has the best vaccine in the world. 

You do know that the results of clinical trials are not issued by those conducting the trials, don't you? The results come from an independent data and safety monitoring board.

  • Like 1
  • Sad 1
Link to comment
Share on other sites

Phase 1 clinical trials are typically about dosage range, not about efficacy and therapeutic effect, those evaluations come in Phases 2 and 3. That being so, while it is encouraging that results of Phase 1 are 'promising', it is a long and hard road through to FDA approval, and most fall at the last few hurdles.

  • Like 1
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.







×
×
  • Create New...